A large clinical trial found that switching to an experimental drug after liquid biopsy detection of treatment-resistant mutations in breast cancer patients substantially extends tumor control and overall health status. The study, conducted at Weill Cornell Medicine, showed better outcomes compared to standard care.
A team at The University of Osaka has proposed micronozzle acceleration to generate giga-electron-volt proton beams in compact setups. This novel concept uses micro-targets with tiny nozzle-like features and ultrashort laser pulses to achieve high-quality, GeV-class proton beams.
A new study published in the American Society for Nutrition found that higher linoleic acid levels were associated with lower risks of heart disease and type 2 diabetes. The research used blood markers to measure linoleic acid levels in nearly 1,900 people, suggesting that this omega-6 fatty acid may support cardiometabolic health.
The ATOMIC trial demonstrates a statistically significant improvement in disease-free survival with the addition of atezolizumab to standard adjuvant FOLFOX chemotherapy. Patients treated with atezolizumab had a 50% lower risk of disease recurrence or death compared to those receiving chemotherapy alone.
A phase 3 trial of patients with surgically resected stage 3 dMMR colon cancer found that adding an immune checkpoint inhibitor (atezolizumab) to standard chemotherapy improved disease-free survival by 50% compared to chemotherapy alone. The study results provide new evidence for a treatment approach in this high-risk patient population.
A new animal study suggests that microscopic plastic particles found in food and beverages may affect glucose metabolism and harm organs such as the liver. Researchers observed dose-correlated changes in mice consuming polystyrene nanoparticles, including systemic glucose intolerance and elevated alanine aminotransferase.
A new study found that adding immunotherapy to chemotherapy after surgery for patients with stage 3 (node-positive) colon cancer resulted in a 50% reduction in cancer recurrence and death compared to chemotherapy alone. The treatment combination showed significant benefits for patients with deficient DNA mismatch repair genetic makeup.
A Dana-Farber study found that patients with stage III colon cancer who consumed an anti-inflammatory diet had longer overall survival post-treatment compared to those on a proinflammatory diet. Engaging in higher levels of physical activity also amplified the positive influence on survival.
A phase I clinical trial demonstrates that dual-target CAR T cell therapy can reduce tumor size in nearly two-thirds of patients with recurrent glioblastoma, a notoriously aggressive brain cancer. The therapy also shows signs of long-term immune system activation and potential for extended tumor stability.
Charité researchers identified a therapeutic target that significantly contributes to halting ongoing inflammatory processes. They found that interleukin-22 and oncostatin M drive inflammation by amplifying the immune response. Targeted treatments may help high-risk patients, but chronic diseases remain complex and difficult to predict.
A recent study published in JAMA Oncology suggests that modern phase 3 oncology trials often prioritize overall survival over quality of life, which may not accurately reflect patient needs. Future trial designs should focus on improving overall survival and quality-of-life outcomes to better represent patient experiences.
Researchers develop a novel analytical method to capture localized structures and reveal the intertwined behavior of multiple fluctuating fields. They introduce two new measures based on information entropy, which quantify structural complexity and degree of coupling between turbulent structures.
Researchers have developed AI-driven models to decode complex genetic information in plants, offering unprecedented insights into plant biology. These models can predict gene functions, regulatory elements, and expression patterns, accelerating crop improvement and enhancing biodiversity conservation.
Researchers found that obese mice displayed more anxiety-like behaviors and showed different signaling patterns in the hypothalamus, a region involved in regulating metabolism. The study also observed distinct differences in the makeup of gut bacteria in obese mice compared to lean mice.
A large study followed nearly 200,000 people for several decades to find that choosing healthy, minimally processed foods is key to protecting the heart. Healthy diet patterns, whether low-carb or low-fat, lowered the risk of developing heart disease by about 15%.